Find the Cracks First: How to Identify Weak Drug Patents Before Paragraph IV Filers Do
In the high-stakes world of pharmaceutical innovation, the race to bring a new drug to market is as much a battle of intellect as it is of strategy. Yet, amidst the flurry of patent filings, clinical trials, and regulatory hurdles, a critical question …
Find the Cracks First: How to Identify Weak Drug Patents Before Paragraph IV Filers Do Read Post »
